**Abbreviations, acronyms & symbols**AAA= Abdominal aortic aneurysmASA= American Society of AnesthesiologistsBMI= Body mass indexEVAR= Endovascular aneurysm repair

INTRODUCTION
============

Abdominal aortic aneurysm (AAA) has a lower incidence in the female population^\[[@r1]\]^, but a higher complication rate^\[[@r2]-[@r5]\]^, especially a higher risk of rupture^\[[@r6]\]^. It was been hypothesized that some different clinical and anatomical characteristics of AAAs in women could be responsible for this higher rate of complications and worse results after treatment.

As the incidence of AAAs is higher in men, the therapeutic indications for AAAs in women are generally extrapolated from studies that have a small number of women, and so they are based mostly on results obtained from men.

We decided to evaluate in our center if gender had influence on the clinical, anatomical characteristics and outcomes after endovascular aneurysm repair (EVAR).

METHODS
=======

A retrospective analysis of our database of patients undergoing EVAR was performed. A total of 171 patients treated between October 2001 and December 2013 and with a diagnosis of infrarenal aortic or aortoiliac aneurysms were included. The adopted surgical criteria were degenerative fusiform aneurysm diameter \>5 cm, aortic aneurysm \<5 cm associated with common iliac artery aneurysm \>3 cm, saccular aneurysms, dissecting aneurysms and pseudoaneurysms. Patients with a diagnosis of ruptured abdominal aneurysm were excluded.

Patients were divided according gender and evaluated regarding age, atherosclerotic risk factors (hypertension, diabetes, smoke history, dyslipidemia), body mass index (BMI), comorbidities (ischemic heart disease, valvular heart disease, heart failure, cardiac arrhythmia, vascular neurological disease, chronic obstructive pulmonary disease, respiratory failure, chronic kidney disease), aneurysm morphology (aortic, right aortoiliac, left aortoiliac, bilateral aortoiliac), aneurysm diameter, neck form (conical, reverse conical, cylindrical, other), neck characteristics (diameter, calcification, thrombus, angulation), iliac morphology (tortuosity and diameter), anatomical risks, internal iliac artery aneurysms, endograft type, American Society of Anesthesiologists (ASA) classification, anesthetic technique, length of stay, reinterventions, and mortality.

Two statistical analysis were performed, the first comparing women (n=10) and men (n=161) (Group A), and the second comparing women (n=10) and an age-adjusted subgroup of men (n=47) (Group B). The statistical analysis included t-tests for two independent samples, analyses of variance in the case of several groups, and chi-square tests for the comparison of proportions concerning categorical variables. Nonparametric tests were used when the normality or homogeneity of variances was not observed. All the analyses were performed with IBM SPSS Statistics, version 22; the statistical significance for twosided tests was assumed to be *P*\<0.05.

RESULTS
=======

Of the 171 patients, 94.2% (n=161) were males and 5.8% (n=10) were females. We analyzed patients undergoing open surgery during the same period and found that 5% were women, with no statistical difference between the proportions (*P*=0.478). The mean age of patients undergoing EVAR was 74.1 years, with the median of 75 years and a standard deviation of 8.9 (min.: 38, max.: 93). In the male population, the mean age was 73.8±8.9 years, while women\'s was 79.8±6.9 years. The female population was statistically older (*P*=0.037).

Clinical characteristics comparison between gender is shown in [Table 1](#t1){ref-type="table"}. In group A, women had statistically fewer association with smoking history, association of atherosclerotic risk factors, and fewer vascular neurological disease, and a trend to a fewer arterial hypertension. In Group B, women had statistically fewer association with smoking history, ischemic heart disease, vascular neurological disease, and a trend to fewer arterial hypertension and atherosclerotic risk factors association.

Table 1Comparison of clinical characteristics between women and men (Groups A and B). **Group A (general)SSGroup B (adjusted by age)SSMen (n=161)Women (n=10)Men (n=47)Women (n=10)**Body Mass IndexBMI \< 2541.8%33.3%N52.3%33.3%NBMI 25-3036.2%66.7%34.1%66.7%BMI\> 3022%013.6%0Hypertension 85.7%40%0.05387.2%40%0.062Diabetes 18.1%20%N23.9%20%NDyslipidemia 68.1%60%N73.9%60%NSmokersActive Smokers17.5%0Y13%0YFormer Smokers61.9%10%Y65.2%10%YNo Smokers31.4%90%Y21.8%90%YPeripheral Arterial Disease 18.1%81.9%N23.9%20%NAtherosclerotic risk factors associationNo risk factor8.1%30%Y8.5%30%0.071-2 risk factors24.2%40%21.3%40%3-4 risk factors56.5%30%63.8%30%≥ 5 risk factors11.2%06.4%0Ischemic Heart Disease54.50%30%N68.9%30%YValvular Heart Disease26.70%33.3%N31.6%33.3%NHeart failure43.90%60%N54.5%60%NCardiac arrhythmia36.50%50%N52%50%NVascular neurological disease12.70%0Y14.9%0YCOPD24.30%20%N26.7%20%NRespiratory Failure5.30%10%N11.1%10%NChronic Kidney Disease22.10%10%N17.4%10%NASA classificationASA II15.8%11.11% 9.3%11.1%NASA III71.7%55.6%72.1%55.6%ASA IV12.5%33.3%18.6%33.3%[^1]

Fig. 1Survival curves by gender.

Detailed aneurysm characteristics are shown in [Table 2](#t2){ref-type="table"}. There was a statistical association between neck angulation \>70º and women and a trend to statistical significance in the association of internal iliac aneurysm and aneurysm diameter \>60 mm, in both groups. In group A, a trend to CIA diameter \>20 mm in women that wasn\'t confirmed when adjusted by age (Group B) was observed.

Table 2Comparison of aneurysm characteristics between women and men (Groups A and B). **Group A (general)SSGroup B (adjusted by age)SSMen (n=161)Women (n=10)Men (n=47)Women (n=10)**Aneurysm MorphologyAortic67.2%40%N68%40%NUnilateral Aortolliac21.8%40%19.1%40%Bilateral Aortolliac11.2%20%12.8%20%IIA Aneurysm 8.9%30%0.078.5%30%0.09Aneurysm Diameter62.1mm66.7mmN60.2mm66.7mmNAneurysm Diameter\<60 mm48.3%20%0.0848.9%20%0.092\>60 mm51.7%80%51.1%80%Neck length\<10 mm11.2%0N15%0N\>10 mm88.8%100%85%100%Neck diameter\<28 mm85.7%87.5%N97.5%87.5%N\>28 mm14.3%12.5%2.5%12.5%Neck calcification\<50%95.9%87.5%N95.2%87.5%N\>50%4.1%12.5%4.8%12.5%Neck thrombus\<50%84.9%87.5%N87.8%87.5%N\>50%15.1%12.5%12.2%12.5%None18.3%12.5%9.5%12.5%Neck angulation\<50°48.6%25%N50%25%N\>50°33.1%62.5%40.5%62.5%\<70°92.3%62.5%Y92%62.5%Y\>70°7.7%37.5%7.1%37.5%Neck shapeConical28.2%25%N24.4%25%NReversal Conical4.9%02.4%0%Cylindrical63.4%75%73.2%75%Other3.5%000Iliac TortuositySmall/Medium76.4%40%N66.7%40%NLarge23.6%60%33.3%60%Right CIA Diameter\<20 mm75.2%50%0.05177.5%50%N\>20 mm14.8%50%22.5%50%Left CIA Diameter\<20 mm75.2%55.6%0.05682.5%55.6%N\>20 mm14.8%44.4%17.5%44%Right EIA 8.7%9.2%N8.8%9.2%NLeft EIA8.5%8.3%N8.5%9.3%N[^2]

The outcomes (anesthesic time, surgical time, need of blood transfusion, lenght of stay, type of endoleak, sac behaviour, intraoperative complications, surgical re-intervention, thirty-day complications, and thirty-day mortality) showed no statistical difference between gender in the two groups ([Tables 3](#t3){ref-type="table"} to [6](#t6){ref-type="table"}).

Table 3Gender and anesthesic time, surgical time, need for blood transfusion, and length of stay (Groups A and B). **Anesthesic time (minutes)ESSurgical time (minutes)ESNeed blood transfusionESLength of stay (days)SSMeanSDMeanSDMeanSD**Group AMen174.664.7N103.249.5N21.3%N6.47.3NWomen170.132.595.326.840.9%5.52.4Group BMen179.448.5N105.834.6N25%N5.63.3NWomen170.132.595.326.850%5.52.4[^3]

Table 6Gender and intraoperative complications, reintervention, thirty-day complications and thirty-day mortality (Groups A and B). **IntraoperativeESRe-interventionThirty-daySSThirty-daySScomplicationsGeneralSSEndoleak IASSEndoleak IBSScomplicationsmortality**Group AMen23.6%N16.1%N4.3%N4.3%N22.7%N1.20%N Women20%20%010%10%0Group BMen25.5%N19.1%N14.3%N0N28.6%N2.10%N Women20%20%010%10%0[^4]

Kaplan Meier curves of postoperative survival by patient\'s gender show a better survival in men but without statistical significance. The median survival in men was 8.5 years, with a standard deviation of 0.5 (95% CI: 7.5-9.5), and 4.6 years in women, with a standard deviation of 0.83 (95% CI: 3-6.2). We can see both survival curves in [Figure 1](#f1){ref-type="fig"}, and there was no statistical significance between them.

DISCUSSION
==========

The surgical indication for AAA is mainly based in two randomized trials^\[[@r7],[@r8]\]^. These studies have shown the benefit of surgery to patients with aortic aneurysms over 5.5 cm, with criteria equal for both genders. However, in these studies there were 83% and 99.2% of males, and so it can be questioned if the treatment proposed can be extended for both genders. Likewise, the 3 cm diameter needed to diagnose an AAA must be questioned if it is suitable for both genders, considering that characteristics like height, body surface and weight are different between males and females.

The larger randomized prospective studies (EVAR-1^\[[@r9]\]^, DREAM^\[[@r10]\]^, OVER^\[[@r11]\]^, ACE^\[[@r12]\]^ and EVAR-2^\[[@r13]\]^) that compared open surgery to EVAR and are seen as references to AAA treatment have a male percentage of 91%, 93%, 99.3%, 100% and 76.8%, respectively. This huge difference makes us wonder if it is reasonable to extrapolate the results to women. Menezes et al. ^\[[@r14]\]^ also has demonstrated this discrepancy in a retrospective regional study, with a male percent of 91.21%.

Due to a lower prevalence of AAA in women, they are excluded from screening programs, but Wanhainen et al.^\[[@r15]\]^ suggest that the prevalence may be underestimated. They state that if the criteria to diagnose an AAA changes from 3 cm in diameter to 1.5 times the diameter of the normal infra-renal aorta, then the prevalence in the age group from 65 to 75 years would go from 16.9% to 12.9% in men and from 3.5% to 9.8% in women.

Mofidi et al.^\[[@r16]\]^ suggest that aneurysm growth is higher in women than in men (3.67 mm/year in women vs. 2.03 mm/year in men, *P*\<0.001). The UK small aneurysm trial also revealed a risk of rupture four times higher in women, and a risk of rupture with lower diameters (5.0±0.8 cm in women vs. 6.0±1.4 cm in men, *P*=0.001).

In 2006, Dillavou et al.^\[[@r17]\]^ revealed that EVAR was done to 28% of the women with AAA and to 44.3% in men. It is supposed that a worse profile of anatomical conditions in women explained this difference.

As for 30-day mortality rate, it was reported to be higher in women undergoing elective surgery and in rupture. Norman & Powell\'s review stated that fatality after elective surgery was 35% to 50% higher in women^\[[@r2]\]^. Heller et al.^\[[@r3]\]^ reported a mortality rate after conventional surgery of 7.7% in women and 5.1% in men. Leon et al.^\[[@r4]\]^ confirmed this mortality difference after conventional surgery, with a mortality of 8.2% in women and 5.2% in men, and after EVAR this difference was even higher: 5.1% in women *vs.* 1.7% in men. In a meta-analysis, Grootenboer et al.^\[[@r5]\]^ gathered 61 studies for a total of 516.118 patients and showed that women with AAA had a higher mortality rate comparing to men in the elective treatment by conventional surgery (7.6% *vs.* 5.1%) and in EVAR (2.9% *vs.* 1.5%).

One should also account for the higher survival in women and their different physiology: until menopause women have hormonal protection; after, this protection is lost, and they have a higher incidence of cardiovascular disease comparing to men.

Starr & Halpern^\[[@r18]\]^ reviewed the current recommendations and recent literature, to help finding the differences between gender. Their review showed that women presented later, have a higher rupture rate, and underwent AAA treatment less than men, and with varied outcomes, with some studies showing similar short-term and long-term results between men and women. They concluded that it must be some genderspecific risks inherent to women, although pathophysiologic mechanisms responsible for the difference in AAA prevalence between gender have not been determined. They affirmed that it is reasonable to recommend routine screening for women older than sixty-five years who have ever smoked or who have a family history of AAA and the need of additional research to elucidate the reasons for differences between men and women.

Skibba et al.^\[[@r6]\]^, in a 14-year retrospective study with 2121 patients and 499 women (23.5%), found that women with AAA were older than men, have a higher frequency of cardiovascular risk factors, had greater risk of rupture at all size intervals and a fourfold increased frequency of rupture at \<5.5 cm.

Preiss et al.^\[[@r19]\]^ searched the differences in late mortality between females undergoing elective EVAR for small and/or slow-growing AAAs compared with those who meet standard criteria at their institution. They analyzed thirty-six women (22% of treated patients) for a mean follow-up time of 37.2 months. Sixteen of the thirty-six women (44.4%) presented an AAA diameter smaller than 5.5 cm or a six-month growing rate shorter than 0.5 cm. This group had a higher late mortality (37.5% *vs.* 5%; *P*=0.03) and a trend toward increased reoperation rate. This fact might compromise the EVAR indication in women who do not meet the standard criteria.

Gloviczki et al.^\[[@r20]\]^ analyzed the outcome results of consecutive patients who underwent EVAR between 1997 and 2011 at a tertiary center, with a total of 934 patients (13% female). They concluded that women had an increased rate of complications and reinterventions, but not a significantly higher mortality.

Chung et al.^\[[@r21]\]^ analyzed 1380 consecutive patients who underwent elective EVAR from 1992 to 2012, of which 214 were women. They referred that women were older and had less cardiac disease, had shorter necks and more angulated, had less iliac aneurysms and they need more adjunctive arterial procedures, with more perioperative complications, longer length of stay and higher rate of endoleaks. Despite more complex aneurysm anatomy and more perioperative complications, aneurysmrelated deaths and overall survival was similar between genders.

Ayo et al.^\[[@r22]\]^, in a retrospective single institution review, showed women with greater neck angulation and higher percent of thrombus, but with advantage in incidence of type I endoleaks (3.5% in men *vs.* 0% in women, *P*=0.381) and overall reinterventions rate (11.3% in men *vs.* 0% in women, *P*\<0.05).

In our experience, EVAR and open surgery were offered independently of the gender, women were older (*P*\<0.05) and had fewer association with smoking, ischemic heart disease, and vascular neurological disease. Concerning the anatomical characteristics, women are more associated to neck angulation \>70º. Besides these anatomical findings, there was no statistical difference in the outcomes of EVAR between the genders.

CONCLUSION
==========

Despite the absence of significant numbers conditioned by the small sample, and despite the inherent limitation of a retrospective non-randomized study, our study shows a clear difference in the clinical and anatomical characteristics of the aneurysms among men and women, but with the same results of EVAR. This should be explored in order to understand the influence of gender in the etiology of AAA.
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###### 

Type of endoleak by gender (Groups A and B).

                        **Group A**   **SS**   **Group B**   **SS**         
  --------------------- ------------- -------- ------------- -------- ----- ---
  No endoleak           59.4%         60%      N             68.90%   60%   N
  Endoleak I or III     10.3%         0        8.90%         0              
  Endoleak II           24.5%         30%      20%           30%            
  Endoleak II + I/III   5.8%          10%      2.20%         10%            

SS=statistical significance; Y=yes; N=no

###### 

Aneurysmal sac behaviour after EVAR (Groups A and B).

                  **Group A**   **SS**   **Group B**   **SS**         
  --------------- ------------- -------- ------------- -------- ----- ---
  Sac growth      10.9%         10%      N             14%      10%   N
  Sac shrinkage   89.4%         90%      86%           90%            
      0-5 mm      21.8%         20%      20.9%         20%            
      5-10 mm     32.7%         20%      25.6%         20%            
      10-15 mm    12.2%         20%      18.6%         20%            
      15-20 mm    9.5%          10%      11.6%         20%            
      20-25 mm    4.8%          20%      4.7%          20%            
      25-30 mm    4.1%          0        2.3%          0              
      \> 30 mm    4.1%          0        2.3%          0              

SS=statistical significance; Y=yes; N=no

[^1]: SS=statistical significance; Y=yes; N=no; ASA=American Society of Anesthesiologists; COPD=chronic obstructive pulmonary disease

[^2]: IIA=internal iliac artery; CIA=common iliac artery; EIA=external iliac artery

[^3]: SS=statistical significance; Y=yes; N=no; SD=standard deviation

[^4]: SS=statistical significance; Y=yes; N=no
